Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes

dc.contributor.authorGallo, Tyler
dc.contributor.authorHeise, C. William
dc.contributor.authorWoosley, Raymond L.
dc.contributor.authorTisdale, James E.
dc.contributor.authorTan, Malinda S.
dc.contributor.authorGephart, Sheila M.
dc.contributor.authorAntonescu, Corneliu C.
dc.contributor.authorMalone, Daniel C.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-05-16T16:54:14Z
dc.date.available2024-05-16T16:54:14Z
dc.date.issued2022
dc.description.abstractBackground: Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high‐risk medications in patients at risk of TdP, but alerts are often ignored. Other risk‐management options can potentially be incorporated in TdP risk CDS. Our goal was to evaluate actions clinicians take in response to a CDS advisory that uses a modified Tisdale QT risk score and presents management options that are easily selected (eg, single click). Methods and Results: We implemented an inpatient TdP risk advisory systemwide across a large health care system comprising 30 hospitals. This CDS was programmed to appear when prescribers attempted ordering medications with a known risk of TdP in a patient with a QT risk score ≥12. The CDS displayed patient‐specific information and offered relevant management options including canceling offending medications and ordering electrolyte replacement protocols or ECGs. We retrospectively studied the actions clinicians took within the advisory and separated by drug class. During an 8‐month period, 7794 TdP risk advisories were issued. Antibiotics were the most frequent trigger of the advisory (n=2578, 33.1%). At least 1 action was taken within the advisory window for 2700 (34.6%) of the advisories. The most frequent action taken was ordering an ECG (n=1584, 20.3%). Incoming medication orders were canceled in 793 (10.2%) of the advisories. The frequency of each action taken varied by drug class (P<0.05 for all actions). Conclusions: A modified Tisdale QT risk score–based CDS that offered relevant single‐click management options yielded a high action/response rate. Actions taken by clinicians varied depending on the class of the medication that evoked the TdP risk advisory, but the most frequent was ordering an ECG.
dc.eprint.versionFinal published version
dc.identifier.citationGallo T, Heise CW, Woosley RL, et al. Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes. J Am Heart Assoc. 2022;11(11):e024338. doi:10.1161/JAHA.122.024338
dc.identifier.urihttps://hdl.handle.net/1805/40811
dc.language.isoen_US
dc.publisherAmerican Heart Association
dc.relation.isversionof10.1161/JAHA.122.024338
dc.relation.journalJournal of the American Heart Association
dc.rightsAttribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePMC
dc.subjectTorsades de Pointes
dc.subjectDecision support systems
dc.subjectClinical
dc.subjectLong QT syndrome
dc.titleClinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gallo2022Clinician-CCBYNC.pdf
Size:
242.3 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: